Concerns over the spread of coronavirus have increased as more countries announced COVID-19 cases in March.

Verdict launched a poll on 13 March to study the concerns over the spread of coronavirus and has been tracking the COVID-19 Concern Index since then through the ongoing poll.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The index is based on respondents, who answered that they are very concerned about the spread of COVID-19.

The COVID-19 Concern Index went northwards from 16 March to hit a high on 31 March, with 80% of the respondents expressing a very high concern. The index was at 71.6% on 16 March.

The concern eased in the second week of April, with the index declining to 75% and has been stable since 11 April. The Index reached a low of 71.34% on 07 April, a level that was witnessed three weeks ago, on 18 March.

The analysis is based on a total of 94,548 responses received up to 13 April. The poll is still running and the analysis will be posted periodically.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Clinical Trials Arena Excellence Awards - Nominations Closed

Nominations are now closed for the Clinical Trials Arena Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Science 37 has won the Research and Development Award in the Site Innovation category for its FDA inspected Direct-to-Patient Site model, delivering nationwide access, faster enrollment and higher retention. Explore how its virtual-first, in home approach is reshaping trial operations and accelerating time to data-driven decisions..

Discover the Impact